M
Mats Remberger
Researcher at Karolinska University Hospital
Publications - 252
Citations - 12645
Mats Remberger is an academic researcher from Karolinska University Hospital. The author has contributed to research in topics: Transplantation & Hematopoietic stem cell transplantation. The author has an hindex of 54, co-authored 238 publications receiving 11726 citations. Previous affiliations of Mats Remberger include Uppsala University Hospital & Karolinska Institutet.
Papers
More filters
Journal ArticleDOI
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.
Katarina Le Blanc,Francesco Frassoni,Lynne M. Ball,Franco Locatelli,Helene Roelofs,Ian D. Lewis,Edoardo Lanino,Berit Sundberg,Maria Ester Bernardo,Mats Remberger,Giorgio Dini,R. Maarten Egeler,Andrea Bacigalupo,Willem E. Fibbe,Olle Ringdén +14 more
TL;DR: Infusion of mesenchymal stem cells expanded in vitro, irrespective of the donor, might be an effective therapy for patients with steroid-resistant, acute GVHD.
Journal ArticleDOI
Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia.
Vanderson Rocha,Jacqueline M. Cornish,Eric L. Sievers,Alexandra H. Filipovich,Franco Locatelli,C Peters,Mats Remberger,Gérard Michel,William Arcese,Sandro Dallorso,Karin Tiedemann,Alessandro Busca,Kawah Chan,Shunichi Kato,Juan Ortega,Marcus R. Vowels,Axel R. Zander,Gerard Souillet,Anthony Oakill,Ann E. Woolfrey,Andrea L. Pay,Ann Green,Federico Garnier,Irina Ionescu,Peter Wernet,Girolamo Sirchia,Pablo Rubinstein,Sylvie Chevret,Eliane Gluckman +28 more
TL;DR: The use of UCBT, as a source of hematopoietic stem cells, is a reasonable option for children with AL lacking an acceptably matched unrelated marrow donor.
Journal ArticleDOI
Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells.
K. Le Blanc,H. Samuelsson,Britt Gustafsson,Mats Remberger,Berit Sundberg,Johan Arvidson,Per Ljungman,Helena Lönnies,S. Nava,Olle Ringdén +9 more
TL;DR: Co-transplantation of MSC resulted in fast engraftment of absolute neutrophil count and platelets and 100% donor chimerism, even in three patients regrafted for graft failure/rejection.
Journal ArticleDOI
A Randomized Trial Comparing Busulfan With Total Body Irradiation as Conditioning in Allogeneic Marrow Transplant Recipients With Leukemia: A Report From the Nordic Bone Marrow Transplantation Group
Olle Ringdén,T. Ruutu,Mats Remberger,J. Nikoskelainen,Liisa Volin,L Vindelov,T Parkkali,S Lenhoff,B Sallerfors,Per Ljungman +9 more
TL;DR: It is concluded that patients treated with busulfan have more early toxicity and an increased transplant-related mortality in patients with advanced disease and TB1 is therefore the treatment of choice, especially in adults and patients withadvanced disease.
Journal ArticleDOI
Graft failure in the modern era of allogeneic hematopoietic SCT
Richard F. Olsson,Richard F. Olsson,Mats Remberger,Mats Remberger,Marie Schaffer,D M Berggren,Britt-Marie Svahn,Jonas Mattsson,Jonas Mattsson,O Ringdén,O Ringdén +10 more
TL;DR: Graft failure was only associated with inferior survival in malignant disease, and non-malignant disorders, HLA match, conditioning intensity, immunosuppression regimen and cell dose all influenced graft failure risk.